The report provides a detailed analysis essential for establishing a Nitroxoline production plant. It encompasses all critical aspects necessary for Nitroxoline production, including the cost of Nitroxoline production, Nitroxoline plant cost, Nitroxoline production costs, and the overall Nitroxoline production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Nitroxoline production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Nitroxoline is an antibiotic mainly used to treat urinary tract infections (UTIs) caused by various bacteria, such as Gram-negative strains like E. coli. It has a broad spectrum of activity. It is effective against both Gram-positive and Gram-negative bacteria, as well as certain fungi. Nitroxoline is also used in disrupting biofilms associated with infections, which aids in the treatment of resistant strains. It also finds application to treat prostatitis, an inflammation of the prostate gland often caused by bacterial infections. Additionally, it also possesses antiangiogenic and anticancer properties by the inhibition of the enzyme MetAP2.
The market demand for Nitroxoline is majorly driven by its application as an antibiotic to treat urinary tract infections (UTIs), which elevates its demand in the medical and pharmaceutical industries. The global rise in the cases of UTIs due to lifestyle changes and increasing traditional antibiotic resistance boosts the demand for newer and effective antibiotics such as Nitroxoline. It witnesses a major demand from the aging population as they are more likely to be affected by UTIs and other bacterial infections. Also, the continuous research into the applications of Nitroxoline beyond UTIs, such as its role in the treatment of certain cancers or biofilm-associated infections, supports its market expansion. Additionally, various innovations in drug delivery systems and formulation techniques also enhance Nitroxoline's efficacy and patient compliance. These factors along with the regulatory approvals in newer indications, further impact the overall industrial Nitroxoline procurement.
Raw Material for Nitroxoline Production
According to the Nitroxoline production plant project report, the key raw materials used in the production of Nitroxoline include 8-Hydroxyquinoline-sodium nitrite-sulfuric acid.
Production Process of Nitroxoline
The extensive Nitroxoline production cost report consists of the following major industrial production process:
- Production from 8-Hydroxyquinoline: The production process of Nitroxoline starts with the reaction of 8-Hydroxyquinoline with sodium nitrite and sulfuric acid to form 8-Hydroxy-5-Nitrosoquinoline as an intermediate. In the next step, the intermediate compound is treated with nitric acid in the presence of acetic acid to produce Nitroxoline (5-nitro-8-hydroxy-quinoline). The final compound undergoes purification by crystallization with the help of DMF and water as solvent systems.
Nitroxoline is an organic compound having the molecular formula C9H6N2O3 and a molecular weight of 190.16 g/mol. It is a light yellow to dark yellow solid powder. It has a melting point of 180 °C. It has an estimated water solubility of 2.73 mg/mL. The value of its partition coefficient, log P, is 1.99. It has a dissociation constant value of 6.89. It is soluble in hydrochloric acid (when heated) but shows very slight solubility in alcohol and diethyl ether. It has antibacterial activity against both Gram-positive and Gram-negative organisms, making it effective for treating urinary tract infections.
